title: Louisiana Birth Outcomes Initiative: improving birth outcomes with interventions before, during, and after pregnancy.
abstract: The costs of poor birth outcomes to the United States in both human and fiscal terms are large and a continuing concern. Louisiana has among the worst birth outcomes in our nation, which include preterm and low birth weight births, and maternal and infant mortality. In response to these poor birth outcomes, the Louisiana Department of Health and Hospitals is implementing a statewide, multi-faceted Birth Outcomes Initiative at the level of the secretary. The Birth Outcomes Initiative aims to adopt evidence-based and best practices along the continuum of care for women and infants. Of particular importance is ending all non-medically indicated deliveries prior to 39 weeks, administration of the hormone 17-hydroxyprogesterone to eligible women for prematurity prevention, optimal behavioral health counseling and referral for reproductive aged women, and ensuring optimal health for women between pregnancies. Opportunities exist to improve outcomes for primary care and obstetrical providers. Louisiana is the first state to aim at improving birth outcomes with interventions before, during, and after pregnancy.
authors.affiliation: Louisiana State University Schools of Public Health and Medicine, USA.
authors.forename: Rebekah E
authors.initials: RE
authors.lastname: Gee
authors.forename: Kay A
authors.initials: KA
authors.lastname: Johnson
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000627:therapeutic use; D055317:Evidence-Based Practice / Q000379:methods / Q000592:standards; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008145:Louisiana / Q000453:epidemiology; D008428:Maternal Mortality; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000191:economics / Q000453:epidemiology*; D047928:Premature Birth / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control*; D011295:Prenatal Care / Q000379:methods / Q000592:standards; D058996:Quality Improvement / Q000458:organization & administration* / Q000592:standards
chemical_list: D019326:17-alpha-Hydroxyprogesterone